Literatur

  1. Baran J, Allendorf DJ, Hong F, Ross GD (2007)
    Oral beta-glucan adjuvanttherapy converts nonprotective Th2 response to protective Th1cell-mediated immune response in mammary tumor-bearing mice. Folia Histochem Cytobiol. 45(2):107-14.
  2. Blum TL, Deslandes Y, Marchessault RH (1982)
    Solid-state and solutionconformation of scleroglucan. Carbohydrate Research 100:117-130 
  3. Brown GD, Gordon S (2001)
    Immune recognition. A new receptor for eta-glucans. Nature 413(6851): 36-37
  4. Brown GD, Gordon S (2003)
    Fungal beta-glucans and mammalian immunity. Immunity 9(3): 311-315
  5. Gawronski M, Park JT, Magee AS, Conrad H (1999)
    Microfibrillar structure ofPGG-glucan in aqueous solution as triple- helix aggregates by small angle x-ray scattering. Biopolymers 50(6):569-578
  6. Graham LM, Tsoni SV, Willment JA, Williams DL, Taylor PR, Gordon S, Dennehy K, Brown GD. (2006)
    Soluble Dectin-1 as a tool to detect betaglucans. J Immunol Methods. 314(1-2):164-9
  7. Herre J, Marshall AS, Caron E, Edwards AD, Williams DL, Schweighoffer E,Tybulewicz V, Reis e Sousa C, Gordon S, Brown GD (2004)
    Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Blood 104(13):4038-4045
  8. Kalac P, Svoboda L (2000)
    A review of trace element concentrations in edible mushrooms. Food Chem 69: 273-281
  9. Kupfahl C, Geginal G, Hof H (2006)
    Lentinan has a stimulatory effect on innate and adaptive immunity against murine Listeria monocytogenes infection. International Immunopharmacology 6:686-696
  10. Luther K, Torosantucci A, Brakhage AA, Heesemann J, Ebel F (2006)
    Phagocytosis of Aspergillus fumigatus conidia by murine macrophages involves recognition bythe dectin-1 beta-glucan receptor and Toll-like receptor 2. Cellular Microbiology 9: 368-381
  11. Mizuno T (1999)
    The extraction and development of antitumor-active polysaccharides from medicinal mushrooms in Japan. Int J Med Mushrooms 1: 9.29
  12. Monschau N, Stahmann KP, Pielken P, Sahm H (1997)
    In vitro synthesis ofb-(1,3)-glucan with a membrane fraction of Botrytis cinerea. Mycol Research 101: 97-101
  13. Oka M, Hazama S, Suzuki M, Wang F, Wadamori K, Iizuka N, Takeda S, Akitomi Y,Ohba Y, Kajiwara K, Suga T, Suzuki T (1996)
    In vitro and in vivo analysis ofhuman leukocyte binding by the antitumor polysaccharide, lentinan. Int J Immunopharmacol. 18(3):211-216.
  14. Palma AS, Feizi T, Zhang Y, Stoll MS, Lawson AM, Diaz-Rodriguez E,Campanero-Rhodes MA, Costa J, Gordon S, Brown GD, Chai W. (2006)
    Ligands for the beta-glucan receptor, Dectin-1, assigned using "designer" microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides. J Biol Chem 281(9):5771-9
  15. Rice PJ, Adams EL, Ozment-Skelton T, Gonzalez AJ, Goldman MP, Lockhart BE,Barker LA, Breuel KF, Deponti WK, Kalbfleisch JH, Ensley HE, Brown GD,Gordon S, Williams DL (2005)
    Oral delivery and gastrointestinal absorption ofsoluble glucans stimulate increased resistance to infectious challenge. J.Pharmacol. Exp. Ther. 314(3):1079-1086
  16. Stahmann KP, Monschau N, Sahm H, Koschel A, Gawronski M, Conrad H, Springer T, Kopp F (1995)
    Structural properties of native and sonicated cinerean, a ß-(1-3)(1-6)-D-glucan produced by Botrytis cinerea. Carbohydrate Research 266: 115-128
  17. Stahmann KP, Schimz KL, Sahm H (1993)
    Purification and characterization of fourextracellular 1,3-beta-glucanases of Botrytiscinerea. J Gen Microbiol 139:2833-2840
  18. Wasser SP (2002)
    Medicinal mushrooms as a source of antitumor andimmunomodulating polysaccharides. Appl. Microbiol. Biotechnol. 60(3):258-274
  19. Zhang L, Li X, Xu X, Zeng F (2005)
    Correlation between antitumor activity,molecular weight, and conformation of lentinan. Carbohydr Res. 2005 Jun 13;340(8):1515-1521
  20. Zhang X, Zhang L, Xu X (2004)
    Morphologies and conformation transition of lentinan in aqueous NaOH solution. Biopolymers 75(2):187-195
  21. Zaidman BZ, Yassin M, Mahajna J, Wasser SP (2005)
    Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol 67: 453-468